News for Snow Eagle Resources Ltd Registered Shs

GlobeNewswire 345d

FluroTech Provides Operational Update: Announces Pause on Further Development of its Pandemic and Emerging Disease Defense Platform

GlobeNewswire 468d

FluroTest Provides System Development Update; Announces Further Progress Optimizing the Immunoassay for SARS-CoV-2 Detection

GlobeNewswire 486d

FluroTest Provides System Development Update; Reports Point of Access Test System and Immunoassay for SARS-CoV-2 Detection is Fully Functional

GlobeNewswire 550d

FluroTest Provides System Development Update; Reports Saliva-based Point of Access Test System and Immunoassay for SARS-CoV-2 Detection is Fully Functional

GlobeNewswire 616d

FluroTest Announces Pre-Emergency Use Authorization Filing with FDA; Provides Executive Update on Program Progress

GlobeNewswire 641d

FluroTest Diagnostic Systems Featured in Grand View Research Report Exploring Growth of COVID-19 Saliva Screening Test Potential Market

PR Newswire 648d

Former US Assistant Health Secretary Dr. Joxel Garcia Joins FluroTest as Chief Medical Officer and Executive Team Member

PR Newswire 648d

Former US Assistant Health Secretary Dr. Joxel Garcia Joins FluroTest as Chief Medical Officer and Executive Team Member

GlobeNewswire 668d

FluroTech Announces Closing of Amalgamation

GlobeNewswire 675d

FluroTech Announces Warrant Incentive Program Results Adding Over $1M to Company Treasury

Seeking Alpha 676d

FluroTest and SNC-Lavalin ink MOU for COVID-19 rapid antigen test platform launch

GlobeNewswire 682d

FluroTech Announces Extension to Early Warrant Exercise Incentive Program

Seeking Alpha 686d

FluroTech ink MOU with Total Testing to launch Covid-19 testing system

GlobeNewswire 706d

FluroTech Announces Early Warrant Exercise Incentive Program

GlobeNewswire 713d

FluroTech Grants Options to the Board of Directors

GlobeNewswire 734d

FluroTech and FluroTest Announce Definitive Amalgamation Agreement

GlobeNewswire 746d

FluroTech Partners With Toolbox Medical Innovations for Clinical Trial of Mass-Scale COVID-19 Testing Platform

GlobeNewswire 749d

Robotics Automation Pioneer Phillip Farrelly Joins Flurotech Scientific Advisory Board

GlobeNewswire 759d

FluroTech and Hudson Robotics Begin Pandemic Response Unit Pre-Production

GlobeNewswire 762d

FluroTech Adds Life Sciences Expert Dr. Timothy J. Holzer to Scientific Advisory Board

GlobeNewswire 774d

Brian Shield, Boston Red Sox VP of IT, Joins Flurotech Advisory Board

GlobeNewswire 775d

FluroTech Provides Executive Update on Program Advancements

GlobeNewswire 781d

FluroTech Retains Market-Making Services

GlobeNewswire 784d

FluroTech Expands nanoComposix Mandate; Initiating Covid-19 Test Performance Evaluation and Validation

GlobeNewswire 787d

FluroTech Announces Closing of Oversubscribed $2.5 Million Private Placement Financing and Announces Communications Engagement for Investor Relations Services

GlobeNewswire 795d

FluroTech Announces Appointment of Regulatory Consultant

GlobeNewswire 798d

FluroTech Announces Closing of First Tranche of Private Placement

GlobeNewswire 821d

FluroTech Announces Exploration of Strategic Options for Cannabis Testing Business to Focus on Pandemic Defense System

GlobeNewswire 833d

FluroTech Announces Non-Brokered Private Placement of Units

GlobeNewswire 837d

FluroTest Systems Ltd. Releases White Paper on the Evolving Role of Antigen Testing in the COVID-19 Pandemic Response

GlobeNewswire 852d

FluroTech Announces Stadium and Arena Product Solution